Dr. Joshua Samuel Jacobs, MD

Dr. Jacobs practices at Allergy & Asthma Medical Group of Diablo Valley Inc in Walnut Creek, California.

Dr. Jacobs' NPI, 1215920673, was assigned on August 31, 2005. Dr. Jacobs graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1990. Dr. Jacobs holds California license G76901.

Dr. Jacobs' primary practice is Allergy & Asthma Medical Group of Diablo Valley Inc, at 370 N Wiget Ln, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 935-6252.

Dr. Jacobs' primary practice is Allergy & Asthma Medical Group of Diablo Valley Inc in Walnut Creek, California. Dr. Jacobs is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is Allergy & Asthma Medical Group of the Bay Area. Dmand AI also links Dr. Jacobs to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jacobs practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Jacobs' primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Jacobs is board certified in allergy and immunology by the National Board of Physicians and Surgeons. Dmand AI has Dr. Jacobs' licenses on file in 2 states: California and Alabama.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Jacobs treats.

CMS data shows 57,207 Medicare services from Dr. Jacobs across 23 procedure codes in 2024, for 335 Medicare patients. Medicare paid $1,279,010 for them. Every service was in an office.

CMS counts 335 Medicare patients who saw Dr. Jacobs in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high cholesterol, and 64% have asthma. 6% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jacobs' median patient age at 52, with 59% women.

In 2024, Dr. Jacobs wrote 1,745 Medicare Part D claims for 285 patients. 58% of them were for generic drugs. CMS names the drug for 1,519 of them, across 34 drugs with 11 or more claims each, at $5,897,350 in total drug cost. In 2023, CMS named 1,547 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Jacobs for performance year 2024, reported as part of a group. Dr. Jacobs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jacobs as offering telehealth.

Dmand AI links 15 papers to Dr. Jacobs, published from 2017 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Angioedemas, Hereditary, Double-Blind Method and Antibodies, Monoclonal, Humanized. Dr. Jacobs has published most often in J Allergy Clin Immunol Pract. Dr. Jacobs' most frequent co-authors are William Raymond Lumry, MD, Timothy J. Craig, DO and Paula J. Busse, MD.

Dmand AI links Dr. Jacobs to 2 clinical trials. Conditions studied include Primary Immunodeficiency Diseases, Rhinitis, Allergic and Immunologic Deficiency Syndromes. Open Payments lists research payments to Dr. Jacobs that name 2 trials.

CMS Open Payments shows 3,341 general payments to Dr. Jacobs from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. AstraZeneca Pharmaceuticals LP paid the most, $415,634. It also lists 12 research payments totaling $13,310 from 2017 to 2024, naming 2 clinical trials.

Dr. Jacobs graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1990.

Dr. Jacobs is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.